Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David C Linehan

Showing results (71-80 of 132) with videos related to

Pageof 14
Sort By:
Surgical Endoscopy|March 7, 2008
Laparoscopic gastric resection for gastrointestinal stromal tumorsJennifer A Sexton, Richard A Pierce, Valerie J Halpin, et al.
Annals of Surgery|June 21, 2014
Natural history of preoperative subcentimeter pulmonary nodules in patients with resectable pancreatic adenocarcinoma: a retrospective cohort studyStephanie T Chang, Dennis C Nguyen, Constantine Raptis, et al.
Journal of Proteome Research|September 2, 2006
Proteins associated with disease and clinical course in pancreas cancer: a proteomic analysis of plasma in surgical patientsYiing Lin, Peter S Goedegebuure, Marcus C B Tan, et al.
Cancer Research|August 2, 2014
CSF1/CSF1R blockade reprograms tumor-infiltrating macrophages and improves response to T-cell checkpoint immunotherapy in pancreatic cancer modelsYu Zhu, Brett L Knolhoff, Melissa A Meyer, et al.
Oncoimmunology|September 20, 2018
Recruitment of CCR2<sup>+</sup> tumor associated macrophage to sites of liver metastasis confers a poor prognosis in human colorectal cancerJulie G Grossman, Timothy M Nywening, Brian A Belt, et al.
Archives of Surgery (Chicago, Ill. : 1960)|August 23, 2012
Microscopic margins and patterns of treatment failure in resected pancreatic adenocarcinomaJennifer L Gnerlich, Samuel R Luka, Anjali D Deshpande, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 24, 2002
Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinomaUdaya K Liyanage, Todd T Moore, Hong-Gu Joo, et al.
Cancer Immunology Research|November 14, 2019
Assessing the Magnitude of Immunogenic Cell Death Following Chemotherapy and Irradiation Reveals a New Strategy to Treat Pancreatic CancerJian Ye, Bradley N Mills, Tony Zhao, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 27, 2006
Increased prevalence of regulatory T cells (Treg) is induced by pancreas adenocarcinomaUdaya K Liyanage, Peter S Goedegebuure, Todd T Moore, et al.
Annals of Surgery|July 25, 2008
Adjuvant interferon-based chemoradiation followed by gemcitabine for resected pancreatic adenocarcinoma: a single-institution phase II studyDavid C Linehan, Marcus C B Tan, Steven M Strasberg, et al.
Pageof 14

Showing results (71-80 of 132) with videos related to

Sort By:
Pageof 14
Surgical Endoscopy|March 7, 2008
Laparoscopic gastric resection for gastrointestinal stromal tumorsJennifer A Sexton, Richard A Pierce, Valerie J Halpin, et al.
Annals of Surgery|June 21, 2014
Natural history of preoperative subcentimeter pulmonary nodules in patients with resectable pancreatic adenocarcinoma: a retrospective cohort studyStephanie T Chang, Dennis C Nguyen, Constantine Raptis, et al.
Journal of Proteome Research|September 2, 2006
Proteins associated with disease and clinical course in pancreas cancer: a proteomic analysis of plasma in surgical patientsYiing Lin, Peter S Goedegebuure, Marcus C B Tan, et al.
Cancer Research|August 2, 2014
CSF1/CSF1R blockade reprograms tumor-infiltrating macrophages and improves response to T-cell checkpoint immunotherapy in pancreatic cancer modelsYu Zhu, Brett L Knolhoff, Melissa A Meyer, et al.
Oncoimmunology|September 20, 2018
Recruitment of CCR2<sup>+</sup> tumor associated macrophage to sites of liver metastasis confers a poor prognosis in human colorectal cancerJulie G Grossman, Timothy M Nywening, Brian A Belt, et al.
Archives of Surgery (Chicago, Ill. : 1960)|August 23, 2012
Microscopic margins and patterns of treatment failure in resected pancreatic adenocarcinomaJennifer L Gnerlich, Samuel R Luka, Anjali D Deshpande, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 24, 2002
Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinomaUdaya K Liyanage, Todd T Moore, Hong-Gu Joo, et al.
Cancer Immunology Research|November 14, 2019
Assessing the Magnitude of Immunogenic Cell Death Following Chemotherapy and Irradiation Reveals a New Strategy to Treat Pancreatic CancerJian Ye, Bradley N Mills, Tony Zhao, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|June 27, 2006
Increased prevalence of regulatory T cells (Treg) is induced by pancreas adenocarcinomaUdaya K Liyanage, Peter S Goedegebuure, Todd T Moore, et al.
Annals of Surgery|July 25, 2008
Adjuvant interferon-based chemoradiation followed by gemcitabine for resected pancreatic adenocarcinoma: a single-institution phase II studyDavid C Linehan, Marcus C B Tan, Steven M Strasberg, et al.
Pageof 14